In a report released today, Yanan Zhu from Wells Fargo maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $50.00. The company’s shares closed ...
In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $48.00. The company’s shares closed ...
Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) focuses on innovation and strategic partnerships to bolster its pipeline and financial position. SAN DIEGO (AP) — Arcturus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback